Amitriptyline Dosing for Depression
For outpatients with depression, start amitriptyline at 75 mg daily in divided doses or 50-100 mg at bedtime, titrate to 150 mg daily as needed, with hospitalized patients potentially requiring up to 200-300 mg daily. 1
Starting Dose
- Outpatients: Begin with 75 mg daily in divided doses, which is usually satisfactory for most patients 1
- Alternative outpatient approach: Start with 50-100 mg at bedtime as a single dose 1
- Hospitalized patients: May require 100 mg daily initially 1
- Adolescents and elderly: Use lower doses—10 mg three times daily with 20 mg at bedtime for those who cannot tolerate higher dosages 1
Titration Schedule
- Outpatient titration: If 75 mg daily is insufficient, increase to 150 mg per day, with increases preferably made in late afternoon and/or bedtime doses 1
- Bedtime dosing titration: When using the bedtime approach, increase by 25-50 mg increments as necessary up to 150 mg per day 1
- Hospitalized patients: Gradually increase from 100 mg to 200 mg daily if necessary 1
- Titration frequency: Increase dosage using increments of the initial dose every 5-7 days until therapeutic benefits or significant side effects appear 2
Maximum Dose
- Standard maximum: 150 mg daily for most outpatients 1
- Hospitalized patients: May require up to 200 mg daily, with a small number potentially needing 300 mg daily 1
- General maximum: 150 mg daily is the typical upper limit, though some guidelines reference up to 300 mg daily for severe cases 2, 3, 4
Maintenance Dosing
- Usual maintenance: 50-100 mg per day is sufficient for most patients 1
- Lower maintenance: Some patients respond adequately to 40 mg per day 1
- Single daily dose: Total daily maintenance dosage may be given as a single dose, preferably at bedtime 1
- Duration: Continue maintenance therapy for 3 months or longer to reduce relapse risk 1
Important Clinical Considerations
Time to Therapeutic Effect
- Sedative effects may appear before antidepressant effects 1
- Adequate therapeutic response may take as long as 30 days to develop 1
- A full therapeutic trial requires at least 4-8 weeks, with at least 2 weeks at maximum tolerated dosage 2, 3
Dosing Strategy Advantages
- Once-daily dosing (particularly at bedtime) has shown superior efficacy compared to three-times-daily dosing in outpatients, with significantly more improvement after 4 weeks 5
- Once-daily dosing offers distinct advantages over conventional multiple doses without differences in dropout rates or side effect reporting 5
Special Populations
- Elderly patients: Require lower starting doses (approximately 50% of adult starting dose) and slower titration due to increased intestinal transit time and decreased hepatic metabolism 6, 1
- Elderly patients should be monitored carefully with quantitative serum levels obtained as clinically appropriate 1
- Pediatric patients: Not recommended for patients under 12 years of age due to lack of experience 1
Monitoring and Adjustments
- Plasma level monitoring may be useful for identifying patients with toxic effects or suspected non-compliance, though it's difficult to directly correlate plasma levels with therapeutic effect 1
- Adjustments should be made according to clinical response rather than plasma levels alone 1
- After 9 months, consider dosage reduction to reassess the need for continued medication 2
Discontinuation
- Taper gradually over 10-14 days to limit withdrawal symptoms 2
Common Pitfalls
- Avoid premature dose escalation: Wait the full 30 days for therapeutic effect before concluding treatment failure 1
- Don't ignore cardiac screening: Obtain screening ECG for patients over 40 years, limit doses to <100 mg/day when possible in patients with cardiac disease 3
- Watch for anticholinergic effects: Somnolence, dry mouth, blurred vision, constipation, weight gain, and prolonged QTc are common 7, 4